rimegepant Tablets, orally disintegrating (ODT) 75 mg
Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP, Canada
Manufacturer #10897
A pharmaceutical manufacturer based in Asia that is active in 80+ countries selling its products in Europe, North America, Africa, the Middle East, CIS, LATAM, and Asia for 40+ years.
The company's production lines are WHO GMP-compliant.
The main dosage forms are tablets, capsules, dry syrups, suspensions, and injections.
The main therapeutic areas include antifungal, analgesics, and psychotropics.
Manufacturer usually replies in 61 days